Utility of somatostatin receptor scintigraphy in pancreatic neuroendocrine neoplasms-Reference-Cited by-同舟云学术

Utility of somatostatin receptor scintigraphy in pancreatic neuroendocrine neoplasms

Published:2019-04-25 Issue:2 Volume:34 Page:78-85
ISSN:0913-0071
Container-title:Suizo
language:en
Short-container-title:Journal of the Japan Pancreas Society

Author:

KURITA Yusuke¹²,KUWAHARA Takamichi¹,MIZUNO Nobumasa¹,OKUNO Nozomi¹,MATSUMOTO Shimpei¹,TORIYAMA Kazuhiro¹,KODA Hiroki¹,OBATA Masahiro¹,HIJIOKA Susumu³,SHIMIZU Yasuhiro⁴,INABA Yoshitaka⁵,NAKAJIMA Atsushi²,KUBOTA Kensuke²,HARA Kazuo¹

Affiliation:

1. Department of Gastroenterology, Aichi Cancer Center

2. Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine

3. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital

4. Department of Gastroenterological Surgery, Aichi Cancer Center

5. Department of Diagnostic and Interventional Radiology, Aichi Cancer Center

Publisher

Japan Pancreas Society

Link

https://www.jstage.jst.go.jp/article/suizo/34/2/34_78/_pdf

Reference22 articles.

1. 1) Krenning EP, Bakker WH, Kooij PP, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992; 33: 652-8.

2. 2) Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009; 27: 4656-63.

3. 3) Bombardieri E, Ambrosini V, Aktolun C, et al. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 2010; 37: 1441-8.

4. 4) Krenning EP, Valkema R, Kooij PP, et al. Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. Ital J Gastroenterol Hepatol 1999; 31 Suppl 2: S219-23.

5. 6) Kubota K, Okasaki M, Minamimoto R, et al. Lesion-based analysis of (18) F-FDG uptake and (111) In-Pentetreotide uptake by neuroendocrine tumors. Ann Nucl Med 2014; 28: 1004-10.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of Quantitative Accuracy and Variability in <sup>177</sup>Lu Imaging Using Monte Carlo Simulation;Japanese Journal of Radiological Technology;2024

2. The Regulatory Review of Radiotherapeutics: A Japanese Perspective;Radiopharmaceutical Therapy;2023

3. Pancreatic neuroendocrine neoplasm with a ring-like enhancement pattern: a case report;Suizo;2021-10-30